Tuesday, November 3, 2026

North Korea’s 9th Party Congress: What Key Economic Strategies Are Being Discussed?

North Korea's 9th Congress focuses on economic strategies, national defense, and modernization, with secrecy around foreign policy discussions.

Luka Modrić Extends AC Milan Contract: What This Means for His Legacy

Luka Modrić extends his AC Milan contract for another year, proving his skill and determination after a stellar World Cup performance.

North Korea Showcases 2024 Economic and Military Achievements, Emphasizes Self-Reliant Defense

North Korea highlights economic and military achievements for 2024, praising Kim Jong Un's leadership and self-reliance initiatives.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Record-Breaking Growth: How Yongma Logistics Achieved 423.8 Billion KRW in 2025

Yongma Logistics achieved record revenue and profit in 2025, driven by strategic enhancements in health and beauty logistics.

How Huons and Sanofi’s Vaccine Partnership Will Transform the Korean Market in 2026

Huons partners with Sanofi to distribute five vaccines in South Korea, enhancing access and leveraging cold chain logistics for better healthcare.

Hugel Hosts Medical Aesthetics Exchange… Expanding Reach of K-Aesthetics

Hugel Inc. hosted a Medical Aesthetics International Exchange, sharing trends and techniques among Asian medical professionals.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

Dialysis Unit Certification Not Just a Label but a “Survival Signal”… Mortality Risk Down 10%

A study reveals that certified dialysis centers in Asia significantly lower patient mortality rates, highlighting the importance of quality care.

How to Spot Hidden Oral Tumors in Cats: Essential Guide for Pet Owners

Oral tumors in cats can be hard to detect. Early diagnosis and a multidisciplinary approach are key for effective treatment and recovery.

2026년 바이오의약품 안전관리: 이상사례 과학적 분석의 모든 것

The FDA enhances adverse event evaluation and guides healthcare providers on self-injectable medications for patient safety.

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

How Wonju’s 150 Billion KRW AI Aesthetic Medical Device Project Will Transform the Beauty Sector by 2030

Wonju City plans to invest 20 billion KRW to enhance its beauty and medical device industries, focusing on AI integration by 2030.

Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer’s Diagnosis with AI Technology

Neurophet partners with ALZ-NET to enhance Alzheimer's care through advanced AI solutions and imaging monitoring for better patient outcomes.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Celltrion’s Groundbreaking Achievement: First Asian Bio Company to Secure APEC CBPR and Global CBPR Certifications

Celltrion becomes the first South Korean biotech firm to earn APEC CBPR and Global CBPR certifications, enhancing global data protection.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.